With 4 global laboratory locations, Q2 Solutions offers a range of next generation sequencing services to support drug discovery, precision medicine, and clinical development. We offer expertise in assay design, development, and validation, plus a translational genomics team comprised of both assay development and bioinformatic scientists, who lead the industry in high complexity testing and analysis. Q2 Solutions offers the following next generation sequencing services:
Service | Capability |
---|---|
Exome Sequencing |
|
RNA Sequencing | Capabilities include:
|
Whole Genome Sequencing | Optimized method for FFPE and intact material, using low input and minimal amplification |
DNA and RNA Isolations | DNA and RNA extraction capabilities from a large spectrum of original material, including FFPE, blood, tissue, and cells |
HTG EdgeSeq Panels |
|
ThermoFisher in Ion Torrent AmpliSeq and Oncomine Panels |
|
NanoString nCounter Panels |
|
Bioinformatics |
|
Q2 Solutions supports our clients by providing integrated laboratory services to global and Asia-Pac regional biopharmaceutical companies who are developing compounds and/or conducting trials. Our...
Retroviral and lentiviral vectors are increasingly being used in the engineering of oncologic cell therapies; however, they may pose risk to human health in the event the viral vector becomes...
Genetic variation in neoplasia can take the form of single or multiple nucleotide variants, gene fusions, amplifications, and/or splice variations. This heterogeneity can pose a challenge in...